Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,813Revenue $M20,393Net Margin (%)12.0Altman Z-Score3.5
Enterprise Value $M58,804EPS $1.6Operating Margin %13.6Piotroski F-Score7
P/E(ttm)23.5Beneish M-Score-2.4Pre-tax Margin (%)12.4Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %0.2Quick Ratio1.3Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %-16.2Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow30.8y-y EBITDA Growth Rate %11.3ROA % (ttm)5.8Higher Current Ratio y-yY
Dividend Yield %2.6PEG--ROE % (ttm)11.3Less Shares Outstanding y-yY
Payout Ratio %69.0Shares Outstanding M1,469ROIC % (ttm)72.6Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTFirst Eagle Investment 2016-03-31 Add0.09%$36.34 - $44.91
($39.68)
$ 38.50-3%Add 12.53%7,507,515
ABTKen Fisher 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 38.50-3%Reduce -10.84%15,413
ABTJoel Greenblatt 2015-12-31 Reduce-0.53%$39.89 - $46.05
($44.24)
$ 38.50-13%Reduce -93.21%98,838
ABTRobert Olstein 2015-12-31 Add0.15%$39.89 - $46.05
($44.24)
$ 38.50-13%Add 14.20%201,000
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 38.50-13%Reduce -13.14%6,027,260
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 38.50-13%Reduce -6.31%4,861,129
ABTGeorge Soros 2015-12-31 Reduce-0.05%$39.89 - $46.05
($44.24)
$ 38.50-13%Reduce -9.20%664,181
ABTFirst Eagle Investment 2015-12-31 Reduce-0.02%$39.89 - $46.05
($44.24)
$ 38.50-13%Reduce -2.26%6,671,344
ABTKen Fisher 2015-12-31 Add$39.89 - $46.05
($44.21)
$ 38.50-13%Add 13.32%17,286
ABTRichard Pzena 2015-09-30 Reduce-0.32%$39.06 - $51.2
($47.14)
$ 38.50-18%Reduce -18.17%5,188,346
ABTJoel Greenblatt 2015-09-30 Add0.16%$39.06 - $51.2
($47.14)
$ 38.50-18%Add 39.49%1,455,289
ABTFirst Eagle Investment 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 38.50-18%Add 15.36%6,825,289
ABTRobert Olstein 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 38.50-18%Add 10.69%176,000
ABTGeorge Soros 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 38.50-18%Add 21.47%731,481
ABTVanguard Health Care Fund 2015-09-30 Reduce-0.06%$39.06 - $51.2
($47.14)
$ 38.50-18%Reduce -8.60%6,938,700
ABTMario Gabelli 2015-09-30 Reduce-0.01%$39.06 - $51.2
($47.14)
$ 38.50-18%Reduce -71.12%17,625
ABTDodge & Cox 2015-09-30 Reduce$39.06 - $51.2
($47.14)
$ 38.50-18%Reduce -3.20%30,268
ABTKen Fisher 2015-09-30 Add$39.06 - $51.2
($47.14)
$ 38.50-18%Add 1.73%15,254
ABTJoel Greenblatt 2015-06-30 Add0.41%$45.89 - $50.03
($47.99)
$ 38.50-20%Add 2409.54%1,043,293
ABTRobert Olstein 2015-06-30 Reduce-0.1%$45.89 - $50.03
($47.99)
$ 38.50-20%Reduce -11.17%159,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NATH DEEPAK S.Senior Vice President 2016-04-28Sell53$41.31-6.8view
Contreras JaimeSenior Vice President 2016-03-31Sell462$41.78-7.85view
Salvadori Daniel Gesua SiveSenior Vice President 2016-02-29Sell881$39.26-1.94view
YOOR BRIAN BSenior Vice President and CFO 2016-02-29Sell865$39.12-1.58view
Mason Heather LExecutive Vice President 2016-02-29Sell3,032$39.27-1.96view
Funck Robert EVice President, Controller 2016-02-29Sell1,333$39.3-2.04view
Warmuth Michael JExecutive Vice President 2016-02-29Sell9,399$38.84-0.88view
Pavee Jean-YvesSenior Vice President 2016-02-29Sell1,665$39.24-1.89view
Ford Robert BExecutive Vice President 2016-02-29Sell1,706$39.28-1.99view
NATH DEEPAK S.Senior Vice President 2016-02-29Sell793$39.27-1.96view

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
Bearish Sentiment in Becton Dickinson's Stock Apr 27 2016 
Stocks Murray Stahl Bought for Past 2 Quarters Apr 26 2016 
A Cheap Dividend Aristocrat Yielding Over 4% Mar 02 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets Dec 11 2015 
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
Profit from Emerging Market Health Care Growth With Abbott Laboratories Jul 25 2015 
Becton and Dickinson: A Long-Term Bet Jul 08 2015 
Mason Hawkins Comments on Abbott Laboratories May 28 2015 
Endo International Posts Upbeat Q1 Results May 13 2015 

More From Other Websites
Charts are bullish for health care: Technician May 05 2016
What Are the Basics of the St. Jude Medical-Abbott Transaction? May 05 2016
Abbott Laboratories (ABT) Is in Oversold Territory: What's Next? May 05 2016
ABBOTT LABORATORIES Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 04 2016
ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report May 04 2016
Abbott to Present at Deutsche Bank Health Care Conference May 04 2016
Rationale for the St. Jude Medical-Abbott Merger Transaction May 04 2016
America's Health Check-up: AARP and Abbott Survey Finds Half of Adults 50-Plus Wish They Had More... May 04 2016
Abbott Laboratories (ABT) Sees Hammer Chart Pattern: Time to Buy? May 04 2016
Abbott Buys St. Jude Medical for $85 per Share in Cash and Stock May 04 2016
As Google's secretive biotech spinoff ramps up, look who it's hiring May 03 2016
[$$] Quintiles and IMS jump on the M&A bandwagon May 03 2016
Weekly Large-Cap Results: Boston Scientific Rose on 1Q16 Earnings May 02 2016
This Undervalued Big Pharma Stock Hit Bottom and Is Ready to Break Out May 02 2016
ST. JUDE MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC... May 02 2016
IHI’s Large-Caps: Abbott to Acquire St. Jude Medical May 02 2016
[$$] Charting the Market Apr 29 2016
[$$] Business Watch Apr 29 2016
Worst may be over for embattled pharma Apr 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)